Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

182 $(1,591) $ 1,057

Diluted earnings

per common share:

(Loss)/earnings

available to

common shareholders

before cumulative

effect of a change

in accounting

principle $(2.08) $0.12 $(1.04) $0.69

Cumulative effect

of a change in

accounting

principle,

net of tax 7/ - - - 0.02

Diluted (loss)/

earnings per

common share $(2.08) $0.12 $(1.04) $0.71

Average common

shares outstanding

- diluted 1,621 1,497 1,536 1,491

The company incurs substantial costs related to the cholesterol joint venture, such as selling, general and administrative costs, that are not reflected in the "Equity income" and are borne by the overall cost structure of Schering-Plough.

1/ Net sales for the three and twelve months ended December 31, 2007,

both include $626 million of Organon BioSciences (OBS) net sales for

the period November 19, 2007 to December 31, 2007.

2/ Cost of sales for the three and twelve months ended December 31, 2007

both include purchase accounting adjustments of $326 million related

to the acquisition of OBS. Cost of sales for the three and twelve

months ended December 31, 2006 include $45 million and $146 million,

respectively, related to the manufacturing changes announced June 1,

2006.

3/ Research and development for the three and twelve months ended

December 31, 2007 include $21 million and $197 million related to

upfront R&D payments. Research and development for the three and

twelve months ended December 31, 2006 both include $15 million related

to an upfront R&D payment.

4/ Acquired in-process research and development for the three a
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... SILVER SPRING, Md. , Dec. 17, 2014 /PRNewswire/ ... today two senior executive promotions as well as changes ... Senior Executive Promotions United ... Ph.D. to President and Co-Chief Executive Officer and ... Chief Operating Officer.  In connection with these promotions, Dr. ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel , Dec. ... BCLI ), a leading developer of adult stem ... subsidiary Brainstorm Cell Therapeutics Ltd. was awarded a grant ... Office of the Chief Scientist (OCS).  This is ... of grant support from the Office of the Chief ...
(Date:12/13/2014)... (PRWEB) December 13, 2014 CanDiag, Inc., ... spin-out company has changed its name to OncoTab, Inc. ... representation of where we are today,” said CEO and ... our platform’s applications beyond breast cancer diagnostics to include ... reflection of that evolution.” , Founded in 2011 by ...
(Date:12/13/2014)... The “Global Synthetic Biology Market (2013-2018)”, analyses ... and challenges. , The global synthetic biology market ... Fisher Scientific, Inc. (U.S.), DuPont (U.S.), and Royal ... approximately ~65% of the total synthetic biology market. ... Report @ http://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html , Thermo Fisher ...
Breaking Biology Technology:United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 2Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 3
... an amazing sight: What looks like a tiny beating heart ... size of a fingernail, floating in a Petri dish. And ... Researchers at The University of Arizona,s Sarver Heart Center and ... come a step closer to repairing hearts damaged by a ...
... Ala. Newly announced National Institutes of Health ... University of Alabama at Birmingham (UAB) research into ... and longevity of total joint replacement components. The ... four-year, $790,931 National Institutes of Health (NIH) grant ...
... , , AMES, Iowa, July ... $7.5 million in a Series D financing to accelerate the clinical ... funding from prior investors. , , ... the expanding field of cancer immunotherapy," said Dr. Charles Link, Chairman ...
Cached Biology Technology:Heart disease: Research off the beating patch 2NIH funds support UAB joint replacement research 2
(Date:12/17/2014)... , Dec. 16, 2014 Research and ... the addition of the "Global Chemical Sensor ... http://photos.prnewswire.com/prnh/20130307/600769 ... the increasing demand for medical sensors in biomedical ... data for quick and correct diagnosis during surgical ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced ... India 2015-2019" report to their offering. ... market is the adoption of multimodal biometric systems. ... of an individual for verification and identification purposes. ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Valencell, a ... it is seeing a staggering demand from its licensees ... the Company revealed, is not solely coming from fitness ... as well. "A wearable is only as ... result, accuracy is the ultimate driver in long-term mass ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... be triggering genetic changes in a species of fruit fly ... and South America about 25 years ago. , "This is ... is occurring, and that genetic change is going along with ... who is co-author of a paper describing the findings, published ...
... the influenza virus determines scientists?ability to survey and control ... the open-access journal PLoS Pathogens, Dr. Eddie C. Holmes ... and colleagues at the National Institutes of Health, the ... genomic analysis to investigate the evolutionary properties of the ...
... demonstrated a new technique that non-invasively measures in real time ... and aging, and initial results suggest that women's skin ages ... of Optics Letters, a journal of the Optical Society of ... of the deeper layers of the skin, combining methods for ...
Cached Biology News:Evolution of Old World fruit flies on three continents mirrors climate change 2Evolution of Old World fruit flies on three continents mirrors climate change 3German researchers develop first non-invasive test to measure skin aging 2German researchers develop first non-invasive test to measure skin aging 3
45° Fixed Angle Rotor for use in the IEC Centra CL2, Centra CL3/CL3R, HN-SII, and the Centra-MP4/MP4R....
... The Lambda 10-2 is a microprocessor ... impressive speed coupled with exceptionally smooth ... for research applications involving fluorescence microscopy, ... any application requiring rapid and accurate ...
... FL is equipped with ... measurement technologies that complement ... advanced features of Fluoroskan ... Fluoroskan Ascent FL provides ...
... an enzyme that catalyzes the hydrolysis ... maltotriose, and dextrins. The,level of a-amylase ... body is of,clinical significance in the ... diabetes; plant and microbial a-amylases are,important ...
Biology Products: